A wide variety of gait alterations have been reported for patients with Dravet syndrome, but the most common seems…
Articles by Joana Carvalho, PhD
Despite the promising anti-seizure effects of cannabinoids in children with Dravet syndrome and Lennox-Gastaut syndrome, more research is needed…
Multimodal analysis that incorporates data obtained from different methodologies seems to be the best approach to build a solid classification…
A deep understanding of the natural history of Dravet syndrome, an early diagnosis, carefully considered treatment, and regular follow-up…
Next-generation sequencing techniques have revealed that genetic mutations in the KCND3 gene may be responsible for more types of epilepsy…
Zogenix has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration…
Lab techniques and bioinformatic tools are essential for helping physicians and scientists distinguish between the benign and disease-causing SCN1A…
Mutations in the SCN1A gene and epileptic seizures contribute to disease severity in a mouse model of Dravet…
GW Pharmaceuticals‘ Epidiolex, the first plant-derived cannabidiol medication to be approved by the U.S. Food and…
Zogenix‘s investigational compound Fintepla (fenfluramine HCl oral solution) improves behavioral and emotional control in children and young adults with…